• Skip to main content
  • 1.919.314.5535
  • infor@avioq.com
  • Products
    • Avioq HTLV-I/II
    • Avioq HIV-1
    • VioOne HIV Profile
    • Biomaterials
  • Services
    • IVD Assay Development
    • IVD Contract Manufacturing
    • Cell Culture Development
  • Contact Us
  • About Avioq
  • Support
    • Product Documentation
    • Technical Support
    • Ordering Information

Avioq HIV-1

  • Overview
  • Technology
  • Benefits
  • Literature
  • Instruments

tryptych-panel1(1)

Avioq HIV-1 KitDerived from purified and inactivated HIV-1 viral lysate proteins, the Avioq HIV-1 Microelisa System is an enzyme-linked immunosorbent assay (ELISA) for the qualitative detection of antibodies to HIV-1 (a leading causal agent of AIDS in the U.S.) in human specimens collected as serum, plasma, dried blood spots, or oral fluid specimens obtained with the OraSure® HIV-1 Oral Specimen Collection Device.
The Avioq HIV-1 Microelisa System is intended for use as an aid in diagnosis of infection with HIV-1. It is not intended for use in screening blood donors.   Developed as a standard two-step indirect microelisa system assay, the Avioq HIV-1 Microelisa System contains coated 96-well microwell plates, color-coded, liquid calibrator and positive control, and a ready-to-use liquid substrate. The sample diluent contains sample addition monitoring to allow visualization of color change upon sample addition to microwells.
Kit Configuration and Principle of Test
The product is available in three kit configurations, the 384, 960, and 9600 test kits. Please refer to the 'Literature' tab for additional information, as well as the performance characteristics of this product. The Package Insert is available on the 'Support' menu tab.
The Avioq HIV-1 Microelisa System uses HIV-1 antigens, including inactivated, purified HIV-1 viral lysate proteins, which are coated on the wells of microwell plates, for the detection of antibodies against HIV-1. Upon addition of a diluted test specimen containing antibodies to HIV-1 to a microwell, immune complexes are formed through the interaction between the anti- HIV in the specimen and the HIV antigens coated on the microwell.
Following incubation, the specimen is aspirated and the well is washed with buffer. Subsequently, anti-human immunoglobulin (goat) conjugated with horseradish peroxidase (HRP) is added which binds to the anti-HIV antigen complex during a second incubation. Following a wash and incubation with ABTS (2,2’-azino-di-(3-ethylbenzthiazoline-6-sulfonate)) substrate, a green color is produced. The enzyme reaction is stopped by the addition of a fluoride solution.
The amounts of antibodies to HIV present in the specimen are qualitatively proportional to color intensity. Because of the use of HIV-1 viral lysate as the primary antigens in the test, significant cross-reactivity with HIV-2 specimens was observed.
Ease of Use
• Fast, convenient procedure suitable for automation
• No sample pre-dilution step
• Color-coded calibrator and positive control
• Sample addition monitoring
Time and Cost-Savings
• Excellent sensitivity and specificity in clinical trials providing reduced cost for confirmatory testing
• High correlation between initial and repeat duplicate results
• High positive predictive value that saves unnecessary confirmatory testing
• Direct dilution into microplate well
Confidence in Results
• Color-coded reagents with sample addition monitoring
• Excellent performance characteristics to provide the “Right Answer Sooner”
Instrument Flexibility
• 96-well microplate with 8-well strips
• 10 uL specimen volume for serum/plasma
• Consistent volumes for Wash Buffer, Conjugate, Substrate, and Stop solutions
Safety
• Specimen diluent (Dilsim III) contains HIV-1 inactivator for safe microplate handling
Avioq HIV-1 Brochure
Avioq HIV-1 Test Procedure
Avioq, Inc. is committed to provide microplate instruments to meet customer needs with our growing menu of immunodiagnostic products. The manual instrument options can meet the needs of low, medium, and high volume testing.
Our microplate instrument offering includes options for ELISA Readers, Washers, Incubator, Pipettor/Dilutor, Computer with Data Analysis Software, and Printers.
Both the Avioq HIV-1 (IVD) and Avioq HTLV-I/II assays utilize 8-well strips with sample and reagent volumes that allow instrument flexibility. This includes compatibility with automated pipetting systems and full automated instruments (pipetting + plate processing).
Options provided by Avioq: these options have the validated Avioq assays that have been programmed into the specific instruments. The following instrumentation with the Avioq programming is available only through Avioq.
AVIOQ PART NUMBERINSTRUMENT TYPE MODEL NUMBER SALES FLYER
200173 Microelisa ReaderBioTek ELx800ELx800 SingleSheet
200174Microelisa ReaderBioTek Elx808 ELx808 New
7560522Test Absorbance PlateBioTek
200170Microelisa Strip WasherBioTek ELx50ELx50 Single Sheet
200172Microelisa Full Plate WasherBioTek ELx405ELx405 Single Sheet
7100745Dispense/Waste SystemBioTek-for ELx405
201280Pipettor/DilutorHamilton 530bHamilton 530b
201180Incubator (Forced Air)10-140AE
201175Computer/Monitor/Keyboard
Includes
Dell
201174 Data Analysis SoftwareBioTek Gen5 CLGen5CL
201179Printer (Laser or Inkjet)Dell or HP

Requirements

Note: For any instrument, the manual provided by the manufacturer should be reviewed for additional information regarding the following:
  1. Installation and special requirements.
  2. Operation principles, instructions, precautions, and hazards.
  3. Manufacturer's specifications and performance capabilities.
  4. Service and maintenance information.
  5. Quality control.

Automated Diluter/Dispenser System (minimum 10 ul with 10% accuracy) or equivalent.

 

Aspiration/Wash System

The aspiration/wash system must be capable of dispensing a minimum volume of 300 µl, and capable of performing a 30 ± 5 second soak cycle. Aspirated waste must be contained in a closed system

Pipettes-Avioq HIV-1

Adjustable multi-channel variable volume pipet system capable of delivering 50 – 300 µl ± 5 %, and tips. Adjustable multi-channel variable volume pipet system capable of delivering 5 – 50 ul ± 5 %, and tips Micropipet(s) capable of delivering: 10 ul ± 10 %, 500 ul ± 5 %, and tips

Pipettes-Avioq HTLV-I/II

Adjustable multi-channel variable volume pipet system capable of delivering 50 – 300 µl ± 5 %, and tips. Micropipet(s) capable of delivering 20 µl ± 5%, 100 µl ± 5%, and tips.

Incubator

A dry incubator, heating block, or equivalent capable of maintaining 37 ± 2 ºC

Microelisa Plate Reader

Any microelisa reader capable of transmitting light at 405 nm for HIV-1. Options for HTLV-I/II are single wavelength at 450 nm ± 5 nm or dual wavelength 450 nm ± 5 nm and 620/630 nm ± 5 nm as reference, with a linear absorbance range of 0 to 2.000, a drift of less than 0.005% AU/hr., and a bandwidth at half height of 10 ± 2 nm may be used.
Avioq, Inc.

104 T.W. Alexander Drive

Research Triangle Park

North Carolina, 27709

United States

Phone: 1.919.314.5535

Email: infor@avioq.com

Products

• Avioq HTLV I/II

 

• Avioq HIV-1

 

• VioOne HIV Profile

 

• GMP Recombinant Proteins

Services

• IVD Assay Development

 

• IVD Contract Manufacturing

 

• Cell Culture Development

 

Contact Us
About Avioq
Support

Copyright @ 2023 Avioq, Inc | Disclaimer